top of page
Home
Calvine Healthcare
Calvine Sustainables
Equity Research
Basilea
Blog
Contact
Use tab to navigate through the menu items.
All Posts
Search
Andrew Keith
Jan 8
Basilea
Brian White
Jan 7
Basilea - Underscoring long term ambitions
Graeme Kyle
Dec 3, 2025
Breedon - on course for net zero
Graeme Kyle
Nov 7, 2025
Volution - investing for climate action
Brian White
Nov 4, 2025
Basilea - Another significant milestone
Andrew Keith
Sep 25, 2025
Basilea - Infectious growth
Brian White
Sep 16, 2025
Basilea - Further BARDA payments
Andrew Keith
Aug 19, 2025
Basilea - Another strong H1
Brian White
Aug 14, 2025
Basilea - a new Phase 3-ready antibiotic
Andrew Keith
Jul 29, 2025
Basilea - Pivotal Phase 3 trial begins
Brian White
Jul 8, 2025
Basilea - More non-dilutive funding
Brian White
Jun 5, 2025
Cresemba's sales momentum continues
Brian White
May 20, 2025
Zevtera launches in the US
Andrew Keith
Apr 28, 2025
Basilea - Going for growth
Brian White
Feb 18, 2025
Another year of strong execution
Andrew Keith
Feb 5, 2025
Basilea - Cresemba's new high
Brian White
Jan 28, 2025
Basilea - A breadth of demand
Brian White
Jan 8, 2025
Basilea - Infectious success
Brian White
Dec 23, 2024
Basilea - Non-dilutive antibiotic funding
Brian White
Dec 16, 2024
Basilea - Ceftobiprole partner secured
bottom of page
